Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Dame Sarah Gilbert from the Pandemic Sciences Institute was awarded the prestigious 2023 King Faisal Prize in recognition of her work to co-create a COVID-19 vaccine that has saved an estimated six million lives.

She accepted the Prize for Medicine at a ceremony last week in Riyadh, Saudi Arabia. The award is in recognition of her work to co-create a vaccine for COVID-19 that has now been used in more than 180 countries and is estimated to have saved more than six million lives.

Launched in 1979, the King Faisal Prize recognises the outstanding works of individuals and institutions in five categories: Service to Islam, Islamic Studies, Arabic Language and Literature, Medicine, and Science. Professor Gilbert received the 2023 Prize for Medicine alongside Professor Dan Barouch of Harvard Medical School.

Professor Gilbert, Saïd Chair of Vaccinology in the Nuffield Department of Medicine, led the University of Oxford’s work to develop the ChAdOx1 nCoV-19 vaccine. The vaccine has widespread global use in the fight against the COVID-19 pandemic – particularly in low- and middle-income countries – due to its low-cost and accessibility.

Accepting the award, Professor Gilbert said: “It is a very great honour to have been awarded this year’s King Faisal Prize for Medicine and to follow in the footsteps of the men and women whose work has been recognised by the King Faisal Foundation over more than four decades.

“This vaccine could not have been produced without an enormous effort by an exceptional team. This includes many scientists at the University of Oxford, our global collaborators, clinical trial volunteers, and of course AstraZeneca. Together we achieved our goal of making a vaccine for the world.

“Much of our success in the last three years must also be attributed to the years of research in vaccine technologies, including work on Middle East Respiratory Syndrome (MERS) in collaboration with researchers in the Kingdom of Saudi Arabia.”

She is donating the prize funds to the Pandemic Sciences Institute, hosted by the Nuffield Department for Medicine, for use in work to protect the world from future pandemic threats. By working together – across sectors, disciplines and geographies – the Pandemic Sciences Institute is developing the vaccines and treatments that will protect humankind from the threat of infectious diseases.

Similar stories